Skip to main content
Clinical Trials/NL-OMON50443
NL-OMON50443RecruitingNot Applicable

Favorable and unfavorable effects of risk-reducing salpingo-oophorectomy (RRSO) in women at high genetic risk of ovarian cancer - HARMOny (Health After eaRly Menopause due to Oophorecomy)

Antoni van Leeuwenhoek Ziekenhuis0 sites750 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
750

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Female patients
  • High genetic risk of ovarian cancer
  • Risk reducing salpingo-oophorectomy before the age of 46, or (for control
  • High genetic risk for ovarian cancer
  • Natural menopause after age of 50 years
  • No RRSO before 55 years of age
  • No treatment induced menopause before 50 years of age

Exclusion Criteria

  • For both groups:
  • History of gynecological cancer at time of RRSO
  • History of cancer at time of testing for BRCA-1 / BRCA-2
  • Ovariectomy for other reasons in patient history
  • Cystectomy in patients history
  • Metastatic disease
  • Other serious comorbidity, psychiatric disorders, which would interfere with a
  • clinic visit
  • Not enough understanding of the Dutch language
  • Non-bioresorbable cardiac stent
  • Younger age than 55 years
  • Premature Ovarian Insufficiency

Investigators

Sponsor
Antoni van Leeuwenhoek Ziekenhuis

Similar Trials